HomeTDACU • NASDAQ
add
Translational Development Acquisition Corp
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 133.39K | -72.43% |
Net income | -8.04K | 98.34% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 438.17K | 21,581.05% |
Total assets | 175.00M | 8,659,008.31% |
Total liabilities | 180.60M | 35,333.70% |
Total equity | -5.60M | — |
Shares outstanding | 21.91M | — |
Price to book | -39.04 | — |
Return on assets | -0.38% | — |
Return on capital | 12.11% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -8.04K | 98.34% |
Cash from operations | -810.96K | — |
Cash from investing | -174.22M | — |
Cash from financing | 175.25M | — |
Net change in cash | 214.14K | 119,064.44% |
Free cash flow | -390.78K | — |
About
Founded
2022
